Trial Profile
Randomized Assessment of patients with clinically suspected Prostate cancer after multiparametric metabolic hybrid Imaging to evaluate its potential clinical Domain: A prospective, randomized, multi-arm, multi-treatment clinical trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Aug 2022
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Acronyms The Rapid study
- 10 Aug 2022 Status changed from recruiting to completed.
- 23 Sep 2015 New trial record